S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
CVE:TUD

Tudor Gold (TUD) Stock Price, News & Analysis

C$0.90
-0.02 (-2.17%)
(As of 05:23 PM ET)
Today's Range
C$0.90
C$0.93
50-Day Range
C$0.80
C$1.15
52-Week Range
C$0.80
C$1.83
Volume
240,012 shs
Average Volume
121,123 shs
Market Capitalization
C$205.78 million
P/E Ratio
N/A
Dividend Yield
6.59%
Price Target
C$2.48

Tudor Gold MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
175.6% Upside
C$2.48 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.45mentions of Tudor Gold in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
C$89,000 Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.12 out of 5 stars

TUD stock logo

About Tudor Gold Stock (CVE:TUD)

Tudor Gold Corp., a junior exploration company, engages in the exploration and development of mineral properties in Canada. The company primarily explores for gold, copper, silver, and other precious and base metals. Its flagship project is the Treaty Creek property covering an area of 17,913 hectares located in the Golden Triangle area to the north of Stewart, British Columbia. The company is headquartered in Vancouver, Canada.

TUD Stock Price History

TUD Stock News Headlines

Tudor Gold (CVE:TUD) Trading Down 2.1%
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
The Wind Up – Watch News #276
See More Headlines
Receive TUD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tudor Gold and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/27/2024
Today
4/19/2024
Next Earnings (Estimated)
7/29/2024

Industry, Sector and Symbol

Industry
Gold
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
C$2.48
High Stock Price Target
C$2.48
Low Stock Price Target
C$2.48
Potential Upside/Downside
+175.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
C$-8,930,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
C$0.04 per share
Book Value
C$0.50 per share

Miscellaneous

Free Float
N/A
Market Cap
C$205.78 million
Optionable
Not Optionable
Beta
1.28
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Mr. Kenneth Konkin P. Geo.
    P.Geo., President, CEO & Director
  • Mr. Scott C. Davis CA (Age 45)
    CGA, CPA, Chief Financial Officer
    Comp: $163.33k
  • Mr. Chris Curran
    Head of Corporate Development & Communications
  • Ms. Frances Murphy
    Corporate Secretary

TUD Stock Analysis - Frequently Asked Questions

Should I buy or sell Tudor Gold stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Tudor Gold in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" TUD shares.
View TUD analyst ratings
or view top-rated stocks.

What is Tudor Gold's stock price target for 2024?

1 Wall Street research analysts have issued 1 year price objectives for Tudor Gold's stock. Their TUD share price targets range from C$2.48 to C$2.48. On average, they expect the company's stock price to reach C$2.48 in the next twelve months. This suggests a possible upside of 175.6% from the stock's current price.
View analysts price targets for TUD
or view top-rated stocks among Wall Street analysts.

How have TUD shares performed in 2024?

Tudor Gold's stock was trading at C$0.95 on January 1st, 2024. Since then, TUD stock has decreased by 5.3% and is now trading at C$0.90.
View the best growth stocks for 2024 here
.

When is Tudor Gold's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, July 29th 2024.
View our TUD earnings forecast
.

How were Tudor Gold's earnings last quarter?

Tudor Gold Corp. (CVE:TUD) released its quarterly earnings results on Tuesday, February, 27th. The company reported ($0.01) earnings per share for the quarter.

How do I buy shares of Tudor Gold?

Shares of TUD stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:TUD) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners